ArticleJournal of thoracic disease2025
Contemporary outcomes of the Fontan operation: a single-institution cohort from China.
Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Outcomes of a Physiology-driven Extracardiac Fontan Strategy Incorporating Computational Fluid Dynamics: A Multicentre Study.European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery · 2026Article
- Revisiting the rhythm: A systematic review and meta-analysis of long-term arrhythmia outcomes after extracardiac versus intracardiac Fontan completion.Annals of pediatric cardiologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The Fontan procedure is the established benchmark for palliating single-ventricle (SV) heart conditions. This study aimed to assess the midterm outcomes of Fontan operations (FOs), focusing on identifying contemporary risk factors for early mortality and Fontan failure. Methods: All patients who underwent FOs between 2005 and 2023 were divided into three cohorts: 2005-2010 (Era I), n=34; 2011-2017 (Era II), n=84; and 2018-2023 (Era III), n=55. These cohorts were categorized based on the surgical techniques employed. Multivariable logistic and Cox regression models were employed to identify potential risk factors. Results: The rates of patients undergoing intra-extracardiac (IE) conduit fenestrated Fontan procedures in the three eras were 0%, 4.8%, and 36.4%, respectively (P<0.001). The frequency of atrioventricular valve (AAV) surgery in Era III was significantly higher than that in Era I (14.5% Conclusions: The outcomes of FOs have improved significantly over the years, with a trend towards more frequent use of IE conduit fenestrated Fontan procedures and the management of increasingly complex diagnose.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.